Remote Monitoring

Remote cardiac monitoring technologies enable patient health to be tracked outside the clinical setting. It can be used for longer term monitoring to help diagnosis arrhythmias or other cardiac conditions. Remote monitoring also can keep tabs on chronic conditions such as heart failure or hypertension and alert clinicians to worsening symptoms to avoid an acute care episode or hospitalization.

FDA clears Google smartwatch tech that calls 911 when a user’s heart stops
Google worked with AI specialists, cardiologists and even stunt performers to develop its new smartwatch feature.
Wearable heart device company to go public, raise up to $155M
Kestra Medical Technologies, known for its wearable heart monitors and defibrillators, intends to sell 10 million common shares priced somewhere between $14 and $16 per share.
FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary
These safety issues have been linked to more than 800 injuries and two deaths. It is possible, the FDA warned, that some patients may require a device to be removed and replaced.
Post-stroke follow-up care considerably worse for women than men
Female stroke survivors are less likely to receive a cardiology referral or undergo cardiac monitoring than their male counterparts.
FDA warns of cybersecurity vulnerabilities in patient monitors
The agency said Contec and Epsimed monitors connected via WiFi are particularly susceptible to cyberattack and could be used to gain access to hospital systems.

Video interview with Matthew Reynolds, MD, who shares data on largest wearable ambulatory cardiac monitoring studies to date from the EXCALIBER and CAMELOT trials at HRS 2024. #HRS #HRS2024 #Remotemonitoring

First large-scale studies of wearable ambulatory cardiac monitoring shed light on usage

Matthew Reynolds, MD, Lahey Hospital and Medical Center, explains data from the EXCALIBER and CAMELOT studies that show ambulatory cardiac monitoring usage among more than 300,000 patients.

Joel Sauer, MBA, MedAxoim, explains why there is a big business trend in cardiology toward remote monitoring and telehealth to cut costs. #ACC #MedAxiom #Telecardiology #remotemonitoring #ACC2024

Telemedicine, remote monitoring help reduce healthcare costs

As profit margins in healthcare continue to shrink, telemedicine and remote monitoring are seeing a large increase to help cut costs while still delivering care outside of the hospital.

Abbott has received U.S. Food and Drug Administration (FDA) clearance for two new over-the-counter continuous glucose monitoring (CGM) devices. While the Lingo system was developed for the general public, helping any adult track their glucose and make healthy lifestyle choices, the Libre Rio was designed specifically for adults with type 2 diabetes.

‘Different products for different people’: FDA clears 2 Abbott over-the-counter glucose monitors

While one of the new devices was developed for the general public, the second was specifically designed for users with type 2 diabetes who do not take insulin.

Jagmeet Singh, MD, PhD, Professor of Medicine, Harvard Medical School, and Founding Director of the Resynchronization and Advanced Cardiac Therapeutics Program at Mass General Hospital, delivered a key note address at HRS 2024 on the future of artificial intelligence in EP and AI applications in cardiology. #HRS #EPeeps #HRS2024 #HRS24 #HealthAI

Embracing AI to enhance EP: Insights from cardiologist Jagmeet Singh

Jagmeet Singh, MD, delivered a keynote address at HRS 2024 on the future of AI in electrophysiology. He spoke to Cardiovascular Business, sharing additional thoughts about the topic.

doctor examines patient data on their tablet

Engineers team with cardiologist to rethink heart pump assessments

The group’s work is focused on how signal processing technologies and machine learning can track the health of VADs and the patients who need them.

WearLinq's eWave six-lead wearable ECG monitor

Wearable ECG specialists acquire new testing facility to reach more patients

San Francisco-based WearLinq says the acquisition will help its six-lead ECG technology reach more heart patients throughout the United States.

Philips presents study results at Heart Rhythm annual meeting demonstrating benefits of its AI-powered cardiac monitoring solutions

With cardiovascular disease on the rise, clinicians and health systems continue to look for ways to deliver high-quality care that is both timely and cost-effective.

The rapid rise of artificial intelligence (AI) has helped cardiologists, radiologists, nurses and other healthcare providers embrace precision medicine in a way that ensures more heart patients are receiving personalized care.

FDA clears advanced AI model for predicting heart failure risk

The new algorithm from Implicity evaluates implantable device data and monitors patients for changes that suggest they could experience severe heart failure symptoms in the near future. It was designed to alert clinicians up to weeks in advance.

Remote Monitoring

FDA clears Google smartwatch tech that calls 911 when a user’s heart stops

Wearable heart device company to go public, raise up to $155M

FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary

Post-stroke follow-up care considerably worse for women than men

FDA warns of cybersecurity vulnerabilities in patient monitors